Marshall Wace LLP Boosts Position in Enhabit, Inc. (NYSE:EHAB)

Marshall Wace LLP boosted its holdings in shares of Enhabit, Inc. (NYSE:EHAB - Free Report) by 4.1% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 949,426 shares of the company's stock after acquiring an additional 37,380 shares during the period. Marshall Wace LLP owned about 1.89% of Enhabit worth $7,415,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Raymond James Financial Inc. bought a new stake in shares of Enhabit in the 4th quarter valued at about $124,000. Advisory Services Network LLC bought a new stake in shares of Enhabit in the 4th quarter valued at about $125,000. Renaissance Technologies LLC boosted its holdings in shares of Enhabit by 5.3% in the 4th quarter. Renaissance Technologies LLC now owns 208,700 shares of the company's stock valued at $1,630,000 after buying an additional 10,532 shares in the last quarter. Invesco Ltd. boosted its holdings in shares of Enhabit by 1.3% in the 4th quarter. Invesco Ltd. now owns 286,676 shares of the company's stock valued at $2,239,000 after buying an additional 3,685 shares in the last quarter. Finally, Wells Fargo & Company MN boosted its holdings in shares of Enhabit by 24.8% in the 4th quarter. Wells Fargo & Company MN now owns 32,294 shares of the company's stock valued at $252,000 after buying an additional 6,415 shares in the last quarter.

Wall Street Analyst Weigh In

Separately, Jefferies Financial Group restated a "buy" rating on shares of Enhabit in a report on Thursday, March 6th.

Enhabit Stock Performance

Shares of Enhabit stock traded up $0.15 during midday trading on Monday, hitting $7.93. The company had a trading volume of 225,459 shares, compared to its average volume of 481,685. The stock has a market cap of $400.31 million, a price-to-earnings ratio of -3.42 and a beta of 1.60. The company has a quick ratio of 1.46, a current ratio of 1.46 and a debt-to-equity ratio of 0.85. The company has a fifty day simple moving average of $8.30 and a 200 day simple moving average of $8.01. Enhabit, Inc. has a 12-month low of $6.85 and a 12-month high of $10.70.

Enhabit Profile

Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.